|
|
|
|
| LEADER |
03238nam a2200301 u 4500 |
| 001 |
EB001843397 |
| 003 |
EBX01000000000000001007386 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180730 r ||| eng |
| 050 |
|
4 |
|a RC564
|
| 100 |
1 |
|
|a Sullivan, Sean
|
| 245 |
0 |
0 |
|a Mindfulness-Based Relapse Prevention for Substance Use Disorders
|h Elektronische Ressource
|b a Systematic Review
|c Sean Grant, Susanne Hempel, Benjamin Colaiaco, Aneesa Motala, Roberta M. Shanman, Marika Booth, Whitney Dudley, Melony E. Sorbero
|
| 246 |
3 |
1 |
|a Systematic Review
|
| 260 |
|
|
|a Santa Monica, CA
|b RAND
|c [2015]©2015, 2015
|
| 300 |
|
|
|a xix, 58 pages
|b color chart
|
| 505 |
0 |
|
|a Preface -- Abstract -- Figures -- Tables -- Summary -- Acknowledgments -- Abbreviations -- Chapter One: Introduction: Description of the Condition -- Description of the Intervention -- How the Intervention Might Work .-- Why It Is Important to Do This Review -- Objective -- Chapter Two: Methods: Key Questions -- Search Strategy -- Eligibility Criteria -- Inclusion Screening -- Data Extraction -- Risk of Bias -- Data Synthesis -- Quality of Evidence -- Chapter Three: Results: Results of the Search .-- Description of Included Studies -- Study Quality and Risk of Bias for Individual Included Studies.-- KQ 1: What Is the Efficacy and Safety of MBRP, as an Adjunctive or Monotherapy, for Any Substance Use Versus Any Comparator? -- Relapse -- Frequency of Substance Use -- Withdrawal/Craving Symptoms -- Treatment Dropout -- Health-Related Quality of Life -- Functional Status -- Recovery Outcomes -- Adverse Events -- KQ 1a: Does the Effect of MBRP Vary by the Substance Targeted (i.e., Alcohol, Opioids, Stimulants, or Cannabis)? -- Alcohol Use -- Stimulant Use -- KQ 1b: Does the Effect of MBRP Differ If MBRP Is Offered as an Adjunctive Therapy Rather Than as a Monotherapy? -- Mindfulness-Based Relapse Prevention as a Monotherapy -- Mindfulness-Based Relapse Prevention as an Adjunctive Therapy.-- KQ 1c: Does the Effect of MBRP on SUDs Depend on the Comparator? -- Mindfulness-Based Relapse Prevention Versus Treatment as Usual -- Mindfulness-Based Relapse Prevention Versus Active Comparator -- Chapter Four: Discussion: Summary of Findings -- Other Reviews in This Area -- Strengths and Limitations -- Implications for Future Research and Practice -- Appendix A: Search Strategy -- Appendix B: Excluded Full-Text Articles -- References
|
| 505 |
0 |
|
|a Includes bibliographical references (pages 53-58)
|
| 653 |
|
|
|a Mindfulness-based cognitive therapy
|
| 653 |
|
|
|a Substance abuse / Treatment
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ZDB-39-JOA
|a JSTOR Open Access Books
|
| 500 |
|
|
|a "RR-1031-OSD."
|
| 776 |
|
|
|z 0833093428
|
| 776 |
|
|
|z 9780833093424
|
| 856 |
4 |
0 |
|u https://www.jstor.org/stable/10.7249/j.ctt19w73qw
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.86
|
| 520 |
|
|
|a "RAND researchers conducted a systematic review that synthesized evidence from randomized controlled trials of Mindfulness-Based Relapse Prevention (MBRP)--used as an adjunctive therapy or monotherapy--to provide estimates of its efficacy and safety for treating adults diagnosed with alcohol, opioid, stimulant, or cannabis use disorder"--Publisher's description
|